LIVE with The Famous Dr AL and Dr. Swathi Varanasi-Diaz

Understanding GLP-1 Drugs and Supporting Muscle Health with Dr. Swathi Varanasi-Diaz

Guest Introduction

Dr. Allen Lycka welcomes Dr. Swathi Varanasi-Diaz, a pharmacist with a postdoctoral residency in integrative medicine and co-founder of the Integrative Health Pharmacy Residency Program. Named one of the 50 Most Influential Leaders in Pharmacy in 2023, Dr. Swathi is a trailblazer in healthcare innovation.

What Are GLP-1 Drugs?

Dr. Swathi explains GLP-1 drugs, a class of medications derived from glucagon-like peptide 1 hormones. These medications regulate blood sugar and appetite and were initially FDA-approved for managing Type 2 diabetes. Popular drugs in this category include:

• Ozempic (semaglutide): Approved for Type 2 diabetes.
• Wegovy: A higher dose aimed at appetite suppression and weight loss.

Risks Associated with GLP-1 Drugs

Dr. Swathi discusses common and lesser-known risks of GLP-1 drugs:

1. Gastrointestinal Issues: Nausea, vomiting, and delayed stomach emptying.
2. Off-Label Misuse: Use by individuals outside approved populations.
3. Mental Health Concerns: Potential adverse effects.
4. Muscle Loss: Accelerated loss of muscle mass, impacting quality of life.

Supporting Muscle Health

Dr. Swathi highlights the importance of preserving muscle health, especially for aging individuals or those on GLP-1 drugs. Her recommendations include:

• Omega-3 Fatty Acids: Found in salmon, chia seeds, or fish oil supplements.
• Branched-Chain Amino Acids (BCAAs): Prevent muscle breakdown and support protein synthesis.
• Fortetropin (MyosMD): A natural compound from fertilized egg yolks that boosts muscle protein synthesis.

Dietary Strategies

For individuals on GLP-1 drugs, Dr. Swathi recommends:

• Eating small, frequent meals with a focus on whole foods.
• Prioritizing high-fiber foods such as fruits, vegetables, and whole grains.
• Considering prebiotic fibers to support gut health.

New and Emerging Drugs

Dr. Swathi introduces other groundbreaking drug classes, such as PCSK9 inhibitors for managing cholesterol in individuals with familial high cholesterol.

Supplements and Clinical Research

Dr. Swathi emphasizes the importance of selecting supplements backed by clinical research and regulated for safety and efficacy.

Connect with Dr. Swathi Varanasi-Diaz

• Instagram and LinkedIn: Search for her name to stay updated.
• Website: Visit www.myosmd.com for educational resources on muscle health and longevity.

Closing Remarks

Dr. Allen Lycka thanks Dr. Swathi for her insights and encourages listeners to visit his website, www.drallenlycka.com, for more information on living a fantastic life.

BIO:

Dr. Swathi Varanasi-Diaz, Pharm.D., is a trailblazing healthcare innovator and the first U.S. pharmacist to complete a postdoctoral residency in integrative medicine. Co-founder of the Integrative Health Pharmacy Residency Program, she combines expertise in biotech, personalized medicine, and clinical research to revolutionize patient care. Named one of the 50 Most Influential Leaders in Pharmacy in 2023, Dr. Swathi is a sought-after advisor, lecturer, and published researcher driving healthcare innovation forward.

Social Media:

https://www.instagram.com/doctorswathi/  

LinkedIn: https://www.linkedin.com/in/swathi-varanasi/   

Website: https://myosmd.com/ or https://myosmd.com/pages/medical-advisors